Evaluation of off-label rapamycin use to promote healthspan in 333 adults

Kaeberlein, T.L., Green, A.S., Haddad, G., Hudson, J., Isman, A., Nyquist, A., Rosen, B., Suh, Y., Zalzala, S., Zhang, X., Blagosklonny, M.V., An, J.Y., &amp; Kaeberlein, M. (2023). Evaluation of off-label rapamycin use to promote healthspan in 333 adults. <em>GeroScience</em>. https://doi.org/10.1007/s11357-023-00818-1

Kaeberlein TL, Green AS, Haddad G, Hudson J, Isman A, Nyquist A, et al. Evaluation of off-label rapamycin use to promote healthspan in 333 adults. GeroScience. 2023. doi:10.1007/s11357-023-00818-1.

@article{tammi2023Evalua, title = {Evaluation of off-label rapamycin use to promote healthspan in 333 adults}, author = {Tammi L. Kaeberlein and Alan S. Green and George Haddad and Johnny Hudson and Anar Isman and Andy Nyquist and Bradley Rosen and Yousin Suh and Sajad Zalzala and Xingyu Zhang and Mikhail V. Blagosklonny and Jonathan Y. An and Matt Kaeberlein}, journal = {GeroScience}, year = {2023}, doi = {10.1007/s11357-023-00818-1}, }